Braveheart Investment Group buys 29.51% of IQ-AI Limited for £0.72 million
LONDON: Braveheart Investment Group (AIM: BRH) has acquired 65.415 million shares of 0.1 pence each in IQ-AI Limited, representing 29.51% of the issued share capital...
IQ-AI receives FDA clearance to market StoneChecker software
LONDON: Imaging Biometrics, IQ-AI’s Milwaukee based subsidiary, received notification that the FDA has cleared StoneChecker Software for marketing in the USA. David Smith, Chief Executive...